The Scientist

» immunotherapy and developmental biology

Most Recent

image: Opinion: Aging, Just Another Disease

Opinion: Aging, Just Another Disease

By | November 1, 2016

No longer considered an inevitability, growing older should be and is being treated like a chronic condition. 

26 Comments

An early-stage study of the effectiveness of a lung-cancer vaccine developed by scientists in Cuba could start as early as next month.

0 Comments

image: Cuban-U.S. Research Collaborations Easier Now

Cuban-U.S. Research Collaborations Easier Now

By | October 18, 2016

President Obama’s executive actions remove some of the red tape for American and Cuban scientists to work together.

0 Comments

image: Bridging a Gap in the Brain

Bridging a Gap in the Brain

By | October 12, 2016

Neuroscientists identify how the left and right hemispheres of the mammalian brain connect during development.

0 Comments

image: Alzheimer’s Immunotherapy Pioneer Dies

Alzheimer’s Immunotherapy Pioneer Dies

By | October 11, 2016

Dale Schenk, who worked to develop a vaccine for Alzheimer’s disease, has passed away at age 59.

0 Comments

image: Further Support for Early-Life Allergen Exposure

Further Support for Early-Life Allergen Exposure

By | September 20, 2016

Egg and peanut consumption during infancy is linked to lower risk of allergy to those foods later in life, according to a meta-analysis.

0 Comments

Scientists estimate the risk to fetuses exposed to the virus in utero.

0 Comments

image: Immunotherapy for Alzheimer’s Disease Shows Promise

Immunotherapy for Alzheimer’s Disease Shows Promise

By | August 31, 2016

Biogen’s aducanumab reduces amyloid-β plaques in a dose-dependent manner, according to interim results of a Phase 1b clinical trial.

3 Comments

Disrupting the light/dark cycles of pregnant mice, researchers observe detrimental effects in the mouths of the animals’ pups.

0 Comments

image: Toward an Immunotherapy for Alzheimer’s Disease

Toward an Immunotherapy for Alzheimer’s Disease

By | July 28, 2016

Targeting tau antibodies does not require effector function, researchers report.

2 Comments

Popular Now

  1. Henrietta Lacks’s Family Seeks Compensation
  2. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  3. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

  4. Abundant Sequence Errors in Public Databases
Business Birmingham